(Q34611796)

3 August 2017

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy (English)

1 reference

3 August 2017

0 references

1 reference

Leonard S Marks

1

1 reference

3 August 2017

Yves Fradet

2

1 reference

3 August 2017

Ina Lim Deras

3

1 reference

3 August 2017

Amy Blase

4

1 reference

3 August 2017

Jeannette Mathis

5

1 reference

3 August 2017

Sheila M J Aubin

6

1 reference

3 August 2017

Anthony T Cancio

7

1 reference

3 August 2017

Marie Desaulniers

8

1 reference

3 August 2017

William J Ellis

9

1 reference

3 August 2017

Harry Rittenhouse

10

1 reference

3 August 2017

Jack Groskopf

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

3 August 2017

1 reference

3 August 2017

69

1 reference

3 August 2017

3

1 reference

3 August 2017

532-535

1 reference

Prostate-specific antigen: update 2006.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

uPM3, a new molecular urine test for the detection of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

The role of prostate needle biopsy in evaluation of chemopreventive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.12.014

10.1016/J.UROLOGY.2006.12.014

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference